The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.

Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

FDA approves Eli Lilly's Omvoh for Crohn's disease, showing strong Phase 3 results in clinical remission and intestinal ...

The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...

A good night's sleep clears the mind like a "dishwasher" cleans crockery, new research suggests. Deep sleep may wash away waste that builds up in the brain during waking hours, say scientists ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

INDIANAPOLIS (WISH) — A 57-year-old woman and a 60-year-old man were found shot dead in a home Wednesday afternoon, and the Marion County Coroner’s Office on Thursday said the woman died as a ...

THURSDAY, Jan. 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adul… ...

Martin Lewis says state pensioners get a free £434 a month with these four conditions. The BBC Sounds podcast host urged over a million pensioners to get in touch with the Department for Work and ...